Market Overview:
The global pneumonia testing market reached a value of US$ XX Million in 2021. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Pneumonia is an infection in the lower respiratory tract caused by bacteria, viruses and fungi. It spreads via the inhalation of airborne droplets from the sneeze or cough of an infected person. It leads to inflammation in the air sacs of the lungs and shortness of breath. It also reduces appetite and causes mild fever, dry cough, headaches, fatigue, chills and chest pain. It is diagnosed through pneumonia testing, which includes a physical examination, medical history review, chest X-ray, blood culture, pulse oximetry, sputum culture, bronchoscopy, and fluid sample.
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Pneumonia Testing Market Trends:
At present, there is a rise in the utilization of point of care (POC) testing to detect pneumonia on account of its higher efficiency and rapid and accurate test results. This, along with the burgeoning healthcare industry, represents one of the key factors driving the market. Moreover, the introduction of immunochromatographic, pneumococcal urinary antigen (UAT) and advanced nucleic acid detection tests is propelling the growth of the market. In addition, the growing awareness among individuals about the benefits of early diagnosis is augmenting the number of pneumonia testing across the globe. This, coupled with the rising healthcare expenditure by governments of several countries, is contributing to the growth of the market. Besides this, there is an increase in the adoption of enzyme-linked immunosorbent assay (ELISA) to detect pneumonia as it is highly sensitive and easier to carry out. Other growth-inducing factors are the growing geriatric population and rising prevalence of pneumonia among children around the world. Furthermore, key market players are focusing on new product launches and approvals which is projected to bolster the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global pneumonia testing market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, method, technology and end user.
Breakup by Type:
Breakup by Method:
- Immunodiagnostics
- Molecular Diagnostics
- Point of Care Testing
Breakup by Technology:
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Enzyme-linked Immunosorbent Assay
- Immunofluorescence
- Western Blot
- Polymerase Chain Reaction
- Immunohistochemistry
- Others
Breakup by End User:
- Hospitals
- Diagnostic Laboratories
- Homecare
- Others
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, Curetis GmbH (OpGen), DiaSorin S.p.A., Hologic Inc, Meridian Bioscience Inc, Quest Diagnostics Incorporated, Quidel Corporation, Roche Holding AG, and Thermo Fisher Scientific Inc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Million |
| Segment Coverage |
Type, Method, Technology, End User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, Curetis GmbH (OpGen), DiaSorin S.p.A., Hologic Inc, Meridian Bioscience Inc, Quest Diagnostics Incorporated, Quidel Corporation, Roche Holding AG, and Thermo Fisher Scientific Inc. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global pneumonia testing market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global pneumonia testing market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the method?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global pneumonia testing market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Pneumonia Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Analyzers
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Consumables
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Method
7.1 Immunodiagnostics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Molecular Diagnostics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Point of Care Testing
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Technology
8.1 Enzyme-linked Immunosorbent Assay
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Immunofluorescence
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Western Blot
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Polymerase Chain Reaction
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Immunohistochemistry
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Diagnostic Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Homecare
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Becton, Dickinson and Company
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 bioMérieux SA
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Bio-Rad Laboratories Inc
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Curetis GmbH (OpGen)
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 DiaSorin S.p.A.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Hologic Inc
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Meridian Bioscience Inc
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Quest Diagnostics Incorporated
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Quidel Corporation
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Roche Holding AG
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.12 Thermo Fisher Scientific Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Pneumonia Testing Market: Major Drivers and Challenges
Figure 2: Global: Pneumonia Testing Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Pneumonia Testing Market: Breakup by Type (in %), 2021
Figure 5: Global: Pneumonia Testing Market: Breakup by Method (in %), 2021
Figure 6: Global: Pneumonia Testing Market: Breakup by Technology (in %), 2021
Figure 7: Global: Pneumonia Testing Market: Breakup by End User (in %), 2021
Figure 8: Global: Pneumonia Testing Market: Breakup by Region (in %), 2021
Figure 9: Global: Pneumonia Testing (Analyzers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Pneumonia Testing (Analyzers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Pneumonia Testing (Consumables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Pneumonia Testing (Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Pneumonia Testing (Immunodiagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Pneumonia Testing (Immunodiagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Pneumonia Testing (Molecular Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Pneumonia Testing (Molecular Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Pneumonia Testing (Point of Care Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Pneumonia Testing (Point of Care Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Pneumonia Testing (Enzyme-linked Immunosorbent Assay) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Pneumonia Testing (Enzyme-linked Immunosorbent Assay) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Pneumonia Testing (Immunofluorescence) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Pneumonia Testing (Immunofluorescence) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Pneumonia Testing (Western Blot) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Pneumonia Testing (Western Blot) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Pneumonia Testing (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Pneumonia Testing (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Pneumonia Testing (Immunohistochemistry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Pneumonia Testing (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Pneumonia Testing (Other Technologies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Pneumonia Testing (Other Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Pneumonia Testing (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Pneumonia Testing (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Pneumonia Testing (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Pneumonia Testing (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Pneumonia Testing (Homecare) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Pneumonia Testing (Homecare) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Pneumonia Testing (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Pneumonia Testing (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: North America: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: North America: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: United States: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: United States: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Canada: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Canada: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Asia-Pacific: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Asia-Pacific: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: China: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: China: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Japan: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Japan: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: India: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: India: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: South Korea: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: South Korea: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Australia: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Australia: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Indonesia: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Indonesia: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Others: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Others: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Europe: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Europe: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Germany: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Germany: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: France: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: France: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: United Kingdom: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: United Kingdom: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Italy: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Italy: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Spain: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Spain: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Russia: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Russia: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Latin America: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Latin America: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Brazil: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Brazil: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Mexico: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Mexico: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Others: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Others: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Middle East and Africa: Pneumonia Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Middle East and Africa: Pneumonia Testing Market: Breakup by Country (in %), 2021
Figure 87: Middle East and Africa: Pneumonia Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Global: Pneumonia Testing Industry: SWOT Analysis
Figure 89: Global: Pneumonia Testing Industry: Value Chain Analysis
Figure 90: Global: Pneumonia Testing Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Pneumonia Testing Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Pneumonia Testing Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Pneumonia Testing Market Forecast: Breakup by Method (in Million US$), 2022-2027
Table 4: Global: Pneumonia Testing Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 5: Global: Pneumonia Testing Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Pneumonia Testing Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Pneumonia Testing Market: Competitive Structure
Table 8: Global: Pneumonia Testing Market: Key Players